Last updated: September 19, 2022
Sponsor: University of Cambridge
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stroke
Treatment
N/AClinical Study ID
NCT04330222
A095132
Ages 18-99 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Symptomatic lacunar stroke with corresponding lacunar infarct on MRI
Exclusion
Exclusion Criteria:
- Unable/unwilling to consent;
- Age<18;
- Stroke aetiology due to cardio-embolism or large vessel disease;
- Lacunar infarcts >1.5cm;
- Severe stroke (NIHSS score ≥16);
- Evidence of cortical infarct of any size;
- Other major neurological diseases;
- Severe systemic diseases such as heart failure, liver failure and kidney failure orany illness in the judgement of the investigator that could affect participation inthe study;
- MRI contraindications e.g. metal objects in or on the body, claustrophobia, pregnancy,known allergy to gadolinium containing contrast agent, impaired renal function withestimated glomerular filtration rate (eGFR) <59ml/min/1.73m2.
Study Design
Total Participants: 210
Study Start date:
March 09, 2020
Estimated Completion Date:
January 12, 2024
Connect with a study center
University of Cambridge
Cambridge, Cambridgeshire CB2 0QQ
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.